Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters

Overview of attention for article published in BMC Cancer, April 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 30 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Risk Factors With Hand-Foot Syndrome in Breast Cancer

U.S.Pharmacist, 18 May 2021

Anthracyclines, in particular doxorubicin, are a mainstay of chemotherapeutic regimens for breast cancer (BC).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.